Novozymes acquires Iogen’s enzyme business
January 31, 2013
January 31, 2013, Ottawa, ON – Novozymes has acquired Iogen Bio-Products, the industrial enzyme business of Ottawa-based Iogen Corporation for $67.5 million (CDN).
The deal provides Novozymes with all commercial rights to Iogen Bio-Products’ existing product portfolio, pipeline, facilities and know-how. Novozymes acquires all of Iogen Corporation’s industrial enzyme business. The acquisition does not include the purchase of assets that relate to Iogen Corporation’s bioenergy process technologies.
Iogen Bio-Products, which entered the industrial enzyme industry in 1991, produces and sells enzymes for the pulp & paper, textile, grain-processing and animal feed industries. The company has close to 70 employees and sells more than 20 products globally.
“Iogen Bio-Products is a good fit for Novozymes,” said Andrew Fordyce, VP of Global Enzyme Sales and Customer Solutions at Novozymes. “We get a number of products that complement our existing product portfolio and welcome a talented group of employees who are very good at developing and producing industrial enzymes.”
Closing of the acquisition is anticipated late February 2013, awaiting finalization of corporate formalities.
Print this page